{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T07:27:36Z","timestamp":1773473256414,"version":"3.50.1"},"reference-count":87,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2022,1,2]]},"DOI":"10.1080\/13543784.2022.2020248","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T08:36:05Z","timestamp":1640248565000},"page":"23-29","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":21,"title":["Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV)"],"prefix":"10.1080","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1329-0209","authenticated-orcid":false,"given":"Harrison C.","family":"Bergeron","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases College of Veterinary Medicine, University of Georgia, Athens, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2924-9956","authenticated-orcid":false,"given":"Ralph A.","family":"Tripp","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases College of Veterinary Medicine, University of Georgia, Athens, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,12,28]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01828-20"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23570"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30322-2"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01537-6"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz059"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2015.11.008"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1080\/10446670410001722131"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1968"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268815003143"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000161"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043951"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.07.057"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-263400"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1586\/17476348.2013.814409"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5245(99)90039-1"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1753696"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0496(199803)25:3<145::AID-PPUL2>3.0.CO;2-L"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1735349"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01302-17"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30292-5"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-019-0149-x"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-013-8368-9"},{"key":"cit0023","first-page":"83","volume":"372","author":"McLellan JS","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199704)51:4<297::AID-JMV7>3.0.CO;2-0"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.5.2918-2925.1995"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.8.6610-6617.1999"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2001.1138"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.000218"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-019-0677-0"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005318"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130517"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.11.6580-6584.2003"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.1.537-540.2006"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.18.9831-9844.2003"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01741-13"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-68-6-1705"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01604-08"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01162-12"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxn074"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1038\/90675"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.3.1600"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.2217\/imt.10.53"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines5030016"},{"issue":"3","key":"cit0044","first-page":"193","volume":"25","author":"Choi Y","year":"2012","journal-title":"Viral Immunol"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2018.04.014"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01755-09"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.24.7683"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.3390\/v5010211"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.3390\/v13020261"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2444"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00621-18"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.260499197"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1126\/science.1243283"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-018-3289-4"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaj1879"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175792"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.01.046"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186854"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9143"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2017.09.009"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-1665"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-0303"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1637762"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.3.531"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201609-1812OC"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30055-9"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.160.10.1070"},{"key":"cit0068","unstructured":"La Fleur P, Argaez C. In palivizumab for infection prevention in inuit infants: a review of the clinical effectiveness and cost-effectiveness. 2019. Edited by. CADTH Rapid Response Reports"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1586\/erp.12.45"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2010.499749"},{"issue":"2","key":"cit0071","first-page":"169","volume":"41","author":"Hernandez-Gago Y","year":"2017","journal-title":"Farm Hosp"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000240"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2015.1125583"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa951"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaj1928"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1126\/science.1234914"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines7010023"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2071"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M604292200"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01296"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01714-16"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001916"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1913556"},{"key":"cit0084","unstructured":"Kemp A. US FDA grants breakthrough therapy designation for potential next-generation RSV medicine MEDI8897. Edited by. 2019. Accessed21 October 2021. https:\/\/www.astrazeneca.com\/media-centre\/press-releases\/2019\/us-fda-grants-breakthrough-therapy-designation-for-potential-next-generation-RSV-medicine-medi8897.html#!"},{"key":"cit0085","unstructured":"Sanofi: Nirsevimab shows positive topline results in RSV Phase 2\/3 MEDLEY trial. Edited by. 2021. Accessed21 October 2021. https:\/\/www.sanofi.com\/en\/media-room\/press-releases\/2021\/2021-06-28-08-00-00-2253567"},{"key":"cit0086","unstructured":"Sanofi: Nirsevimab demonstrated protection against respiratory syncytial virus disease. in healthy infants in Phase 3 trial 2021."},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25265-4"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2022.2020248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T12:29:03Z","timestamp":1645705743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2022.2020248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,28]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,2]]}},"alternative-id":["10.1080\/13543784.2022.2020248"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2022.2020248","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-09-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}